Class Action Lawsuit Commences Against Indivior PLC Over Investment Losses

Investors who have experienced financial losses with their investments in Indivior PLC INDV, a company that specializes in opioid addiction treatment drugs, have an opportunity to join a class action suit initiated by Levi & Korsinsky, LLP. The suit alleges securities fraud and seeks to recover losses for those who invested in Indivior. Based in North Chesterfield, Virginia, Indivior PLC is known for its buprenorphine-based prescription drugs aimed at addressing opioid dependence and related disorders.

Notice of Legal Action

On August 28, 2024, Levi & Korsinsky, LLP publicly announced a class action lawsuit targeting Indivior PLC INDV on behalf of the company's investors. The legal claim revolves around allegations that Indivior may have provided misleading financial statements or failed to disclose critical information, negatively impacting investors' share values.

Participation in the Class Action

Potential participants in the lawsuit are advised to consider their eligibility for joining the action if they have purchased Indivior stock and have incurred losses. Levi & Korsinsky, LLP is encouraging affected shareholders to get in touch, thereby facilitating the process of potentially recovering investment losses through legal means.

lawsuit, investors, recovery